Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn Ericsson S, Johansson KA, Ekberg L, Morhed E, Paludan M, Wittgren L, Blomgren H, Lewensohn R. Baumann P, et al. Among authors: ekberg l. Acta Oncol. 2006;45(7):787-95. doi: 10.1080/02841860600904862. Acta Oncol. 2006. PMID: 16982541
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JS, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Baumann P, et al. Among authors: ekberg l. Radiother Oncol. 2008 Sep;88(3):359-67. doi: 10.1016/j.radonc.2008.07.019. Epub 2008 Sep 1. Radiother Oncol. 2008. PMID: 18768228 Clinical Trial.
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Baumann P, et al. Among authors: ekberg l. J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681. Epub 2009 May 4. J Clin Oncol. 2009. PMID: 19414667 Clinical Trial.
NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
Wennberg BM, Baumann P, Gagliardi G, Nyman J, Drugge N, Hoyer M, Traberg A, Nilsson K, Morhed E, Ekberg L, Wittgren L, Lund JÅ, Levin N, Sederholm C, Lewensohn R, Lax I. Wennberg BM, et al. Among authors: ekberg l. Acta Oncol. 2011 May;50(4):518-27. doi: 10.3109/0284186X.2010.543695. Epub 2011 Jan 4. Acta Oncol. 2011. PMID: 21198416
Swedish Lung Cancer Radiation Study Group: predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer.
Holgersson G, Hoye E, Bergqvist M, Ekman S, Nyman J, Helsing M, Friesland S, Holgersson M, Ekberg L, Blystad T, Ewers SB, Mörth C, Löden B, Henriksson R, Bergström S. Holgersson G, et al. Among authors: ekberg l. Acta Oncol. 2012 Jul;51(6):759-67. doi: 10.3109/0284186X.2012.681064. Acta Oncol. 2012. PMID: 22793039
The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy.
Holgersson G, Sandelin M, Hoye E, Bergström S, Henriksson R, Ekman S, Nyman J, Helsing M, Friesland S, Brodin O, Holgersson M, Lundström KL, Janson C, Ekberg L, Mörth C, Blystad T, Ewers SB, Löden B, Bergqvist M. Holgersson G, et al. Among authors: ekberg l. Anticancer Res. 2012 Apr;32(4):1339-46. Anticancer Res. 2012. PMID: 22493368
Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
Zackrisson B, Kjellén E, Söderström K, Brun E, Nyman J, Friesland S, Reizenstein J, Sjödin H, Ekberg L, Lödén B, Franzén L, Ask A, Wickart-Johansson G, Lewin F, Björk-Eriksson T, Lundin E, Dalianis T, Wennerberg J, Johansson KA, Nilsson P. Zackrisson B, et al. Among authors: ekberg l. Radiother Oncol. 2015 Oct;117(1):99-105. doi: 10.1016/j.radonc.2015.09.024. Epub 2015 Sep 29. Radiother Oncol. 2015. PMID: 26427805 Clinical Trial.
Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN study.
Zackrisson B, Nilsson P, Kjellén E, Johansson KA, Modig H, Brun E, Nyman J, Friesland S, Reizenstein J, Sjödin H, Ekberg L, Lödén B, Mercke C, Fernberg JO, Franzén L, Ask A, Persson E, Wickart-Johansson G, Lewin F, Wittgren L, Björ O, Björk-Eriksson T. Zackrisson B, et al. Among authors: ekberg l. Radiother Oncol. 2011 Jul;100(1):41-8. doi: 10.1016/j.radonc.2010.12.010. Epub 2011 Feb 3. Radiother Oncol. 2011. PMID: 21295880 Clinical Trial.
26 results